Oracle (ORCL) PT Raised to $147 at Barclays, 'RPO Strength And Capex Ramp Point To Better Times Ahead'
Barclays analyst Raimo Lenschow raised the price target on Oracle (NYSE: ORCL) to $147.00 (from $140.00) while maintaining a Overweight rating.
The analyst comments "Q3 in itself was a solid quarter for ORCL with slightly better application and infrastructure growth. However, the items investors will more likely focus on are higher Capex this quarter and expected next FY ($2.1bn for Q3 underlying, $10bn for FY25) along with healthy RPO growth as this suggests higher cloud growth ahead."